Aier Eye Hospital Group Co., Ltd. (300015)

Basic

  • Market Cap

    CN¥149.35B

  • EV

    CN¥147.44B

  • Shares Out

    9,328.41M

  • Revenue

    CN¥19.11B

  • Employees

    32,326

Margins

  • Gross

    50.71%

  • EBITDA

    28.49%

  • Operating

    24.88%

  • Pre-Tax

    23.08%

  • Net

    17.53%

  • FCF

    23.27%

Returns (5Yr Avg)

  • ROA

    12.63%

  • ROE

    19.12%

  • ROCE

    26.4%

  • ROIC

    20.67%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    CN¥25.52

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    CN¥2.1

  • Earnings (Dil)

    CN¥0.37

  • FCF

    CN¥0.49

  • Book Value

    CN¥2.01

Growth (CAGR)

  • Rev 3Yr

    20.85%

  • Rev 5Yr

    19.92%

  • Rev 10Yr

    25.78%

  • Dil EPS 3Yr

    24.72%

  • Dil EPS 5Yr

    26.18%

  • Dil EPS 10Yr

    30.08%

  • Rev Fwd 2Yr

    26.45%

  • EBITDA Fwd 2Yr

    33.07%

  • EPS Fwd 2Yr

    30.39%

  • EPS LT Growth Est

    27.87%

Dividends

  • Yield

    —

  • Payout

    20.86%

  • DPS

    CN¥0.08

  • DPS Growth 3Yr

    13.42%

  • DPS Growth 5Yr

    7.29%

  • DPS Growth 10Yr

    30.67%

  • DPS Growth Fwd 2Yr

    44.54%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Jan '22
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Jan '22
Dec '22
LTM

Revenues

7,997.3

9,973.9

11,900.1

14,972.9

16,068.8

19,064.5

Other Revenues, Total

11.3

16.2

12.3

27.9

41.1

41.1

Total Revenues

8,008.6

9,990.1

11,912.4

15,000.8

16,109.9

19,105.6

Total Revenues % Chg.

34.3%

24.7%

19.2%

25.9%

7.4%

16.1%

Cost of Goods Sold, Total

4,245.4

5,065.0

5,835.1

7,212.4

7,980.5

9,417.7

Gross Profit

3,763.2

4,925.1

6,077.3

7,788.4

8,129.4

9,687.9

Selling General & Admin Expenses, Total

1,898.2

2,354.6

2,493.0

3,406.0

3,850.9

4,464.8

Provision for Bad Debts

74.9

68.4

90.5

97.9

77.3

66.4

R&D Expenses

96.7

151.3

163.2

221.2

269.9

313.6

Other Operating Expenses

12.9

22.2

28.3

41.3

44.6

90.5

Other Operating Expenses, Total

2,082.8

2,596.5

2,775.0

3,766.4

4,242.7

4,935.3

Operating Income

1,680.4

2,328.7

3,302.3

4,022.0

3,886.7

4,752.6

Interest Expense, Total

-54.9

-68.9

-75.4

-164.7

-177.6

-193.1

Interest And Investment Income

61.9

121.9

197.9

199.5

131.6

154.6

Net Interest Expenses

7.0

53.0

122.5

34.9

-46.1

-38.6

Currency Exchange Gains (Loss)

13.6

9.6

-21.3

42.9

129.0

129.0

Other Non Operating Income (Expenses)

-192.4

-22.2

-36.0

-44.9

-38.2

46.3

EBT, Excl. Unusual Items

1,508.7

2,369.1

3,367.5

4,054.8

3,931.4

4,889.2

Impairment of Goodwill

-110.1

-313.7

-361.5

-216.7

-95.3

-95.3

Gain (Loss) On Sale Of Investments

-38.4

-56.4

-380.4

-448.4

-356.9

-285.3

Gain (Loss) On Sale Of Assets

-3.5

-0.9

0.9

0.1

-1.3

-2.6

Asset Writedown

—

-4.0

-4.4

-4.3

-5.0

-4.8

Other Unusual Items

23.7

-153.9

-258.8

-237.8

-137.9

-91.5

EBT, Incl. Unusual Items

1,380.2

1,840.2

2,363.3

3,147.8

3,335.1

4,409.7

Income Tax Expense

314.4

409.1

486.1

677.9

646.1

773.4

Earnings From Continuing Operations

1,065.8

1,431.2

1,877.2

2,469.9

2,689.0

3,636.4

Minority Interest

-56.9

-52.2

-153.4

-146.6

-164.8

-287.9

Net Income

1,008.9

1,378.9

1,723.8

2,323.3

2,524.2

3,348.4

Net Income to Common Incl Extra Items

1,008.9

1,378.9

1,723.8

2,323.3

2,524.2

3,348.4

Net Income to Common Excl. Extra Items

1,008.9

1,378.9

1,723.8

2,323.3

2,524.2

3,348.4

Total Shares Outstanding

8,820.4

8,818.7

9,025.3

9,130.4

9,329.5

9,328.4

Weighted Avg. Shares Outstanding

8,796.3

8,799.8

8,922.4

9,054.3

8,992.6

9,084.8

Weighted Avg. Shares Outstanding Dil

8,804.0

8,799.8

8,922.4

9,054.3

8,992.6

9,098.9

EPS

0.1

0.2

0.2

0.3

0.3

0.4

EPS Diluted

0.1

0.2

0.2

0.3

0.3

0.4

EBITDA

1,943.2

2,681.0

3,718.2

4,511.2

4,490.8

5,442.8